Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy

Variation in chitotriosidase values measured on simultaneous samples by two commercial laboratories

(2013) Sandra Sirrs et al.   AMERICAN JOURNAL OF HEMATOLOGY

Miglustat therapy in type 1 Gaucher disease: Clinical and safety outcomes in a multicenter retrospective cohort study

(2013) David J. Kuter et al.   BLOOD CELLS MOLECULES AND DISEASES

Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes

(2012) L. van Dussen et al.   HAEMATOLOGICA

Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease

(2012) Michael A den Bakker et al.   HISTOPATHOLOGY

Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response

(2011) N. Dekker et al.   BLOOD

Markers of Bone Turnover in Gaucher Disease: Modeling the Evolution of Bone Disease

(2011) L. van Dussen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies

(2011) Johannes M. F. G. Aerts et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Osseous Manifestations of Adult Gaucher Disease in the Era of Enzyme Replacement Therapy

(2011) Patrick B. Deegan et al.   MEDICINE

Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply

(2010) Ari Zimran et al.   BLOOD CELLS MOLECULES AND DISEASES

Potential biomarkers of osteonecrosis in Gaucher disease

(2010) Elena V. Pavlova et al.   BLOOD CELLS MOLECULES AND DISEASES

Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage

(2010) Pilar Giraldo et al.   BLOOD CELLS MOLECULES AND DISEASES

Enzyme replacement therapy “drug holiday”: Results from an unexpected shortage of an orphan drug supply in Australia

(2010) Jack Goldblatt et al.   BLOOD CELLS MOLECULES AND DISEASES

Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis

(2009) Rolf G. Boot et al.   CLINICA CHIMICA ACTA

Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose – response relationships

(2009) Carla EM Hollak et al.   EXPERT OPINION ON PHARMACOTHERAPY

Common G102S polymorphism in chitotriosidase differentially affects activity towards 4-methylumbelliferyl substrates

(2009) Anton P. Bussink et al.   FEBS Journal

Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature

(2008) M. de Fost et al.   ANNALS OF HEMATOLOGY

Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy

(2008) M. de Fost et al.   HAEMATOLOGICA